08/26/2025
3:08 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
08/20/2025
4:17 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/19/2025
9:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
3:14 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
08/12/2025
3:16 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
08/12/2025
3:19 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
08/12/2025
9:31 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
08/12/2025
7:31 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
5:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form D
Notice of Exempt Offering of Securities | |
08/01/2025
11:23 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
08/01/2025
11:23 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for SLXN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/01/2025
11:29 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
11:17 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
8:13 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
07/29/2025
8:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2025
11:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form PRE 14A | |
07/16/2025
7:55 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
8:15 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2025
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K/A | |
07/08/2025
8:35 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2025
8:29 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
06/26/2025
3:15 PM | Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SCHEDULE 13D/A | |
06/23/2025
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEFA14A | |
06/16/2025
9:51 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
05/29/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
05/29/2025
9:14 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
3:04 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
05/23/2025
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
8:20 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
4:01 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
05/13/2025
10:36 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
11:12 AM | CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G/A | |
05/06/2025
7:35 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
05/01/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/29/2025
3:10 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form AW | |
04/29/2025
3:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/29/2025
11:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
04/27/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/23/2025
3:28 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/23/2025
8:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
04/10/2025
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/10/2025
3:09 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form POS AM | |
04/01/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
04/01/2025
3:45 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
03/28/2025
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:42 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
6:27 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
03/14/2025
5:59 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
7:46 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:31 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/30/2025
8:26 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2025
7:56 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
11:19 AM | CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/21/2025
4:49 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SCHEDULE 13G | |
01/17/2025
5:56 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
5:44 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B4 | |
01/15/2025
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
01/15/2025
5:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
4:02 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:19 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
5:00 AM | Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2024
6:08 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:41 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
8:42 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
7:48 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/29/2024
5:06 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/27/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:30 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/20/2024
5:15 AM | Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
11/14/2024
8:03 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
4:24 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/22/2024
8:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
10/16/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
10/16/2024
8:32 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
10/10/2024
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form PRE 14A | |
10/09/2024
5:04 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/01/2024
5:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
6:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/18/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/17/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
09/09/2024
6:33 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
09/09/2024
7:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
MarketBeat All Access